comprehensive
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Life sciences deals on track to hit lowest point since 2017
Next article: Life sciences deals on track to hit lowest point since 2017
focus
hotspot
-
Akero's treatment for NASH falls short in cirrhosis study
2025-09-28 22:37 -
Takeaways from AdvaMed, the largest medical devices conference
2025-09-28 21:50 -
Life sciences deals on track to hit lowest point since 2017
2025-09-28 21:49 -
How should state employee insurance handle Wegovy?
2025-09-28 21:37 -
There’s no way to know how good AI health technologies are
2025-09-28 21:25 -
With clinical trial data readouts, here's how to spot spin
2025-09-28 21:22